Reuters Health Report

Click to View in Browser 03/11/2014 U.S. top court case highlights unsettled science in contraception NEW YORK (Reuters) - - As the U.S. Supreme Court prepares to hear a religious dispute over the Obamacare contraception mandate, advocates on both sides are trying to set the court straight on the science. Bayer's Nexavar misses target in liver cancer trial FRANKFURT (Reuters) - Germany's Bayer said a final stage Phase III clinical trial of cancer drug Nexavar as an adjuvant therapy for liver cancer did not meet its main target. Court denies Myriad motion to block rival genetic tests (Reuters) - Myriad Genetics Inc said a U.S. court denied its motion to temporarily stop rival Ambry Genetics Corp from selling products similar to Myriad's gene-based cancer test, the latest setback for the diagnostics company. Ranbaxy scrambles for ingredients to make generic Nexium MUMBAI/LONDON (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd is in talks with at least two companies on sourcing ingredients for a generic version of AstraZeneca Plc's heartburn drug Nexium, a source said, to ensure the pills can be sold in the United States. U.S. cancer doctors urge payment fix as cases set to rise WASHINGTON (Reuters) - U.S. cancer doctors are worried about their ability to handle an expected surge in cancer cases in the coming years as they face cuts to government health plans and efforts to reduce payments to physicians. Sanofi, UCB set up drug development partnership PARIS (Reuters) - French and Belgian drugmakers Sanofi and UCB have entered a partnership aimed at finding treatments for so-called immune-mediated diseases in areas such as rheumatoid arthritis and inflammatory bowel conditions. Nepal's miracle gel saves newborns from infection DHULIKHEL, Nepal, March 11 (Thomson Reuters Foundation) - Sangita Shrestha desperately waits in a hospital bed to see the baby girl she has just delivered. In the next room, a nurse applies a gel to the stump of the newborn's umbilical cord, wraps her in cloth and places her in a cot next to her mother. Exclusive: Germany OKs Northwest Bio brain cancer drug, shares soar (Reuters) - Germany has granted Northwest Biotherapeutics Inc special permission to sell its experimental brain cancer drug in the country, the company said, and its stock jumped as much as 36 percent. Hearing-aid apps pump up the volume, double as headphones TORONTO (Reuters) - New smartphone apps that link to hearing aids are helping people with impaired hearing to pump up the volume on their devices or to use them as headphones to stream phone calls, YouTube videos and music. US administration pulls back on Medicare drug benefit proposals WASHINGTON (Reuters) - The Obama administration, in an abrupt about-face, said on Monday it would drop proposed changes to Medicare drug coverage that met wide opposition on grounds they would harm health benefits for the elderly and disabled. Related Video Finnish cars finish life as pots and pans Luxury driverless concept car offers view to the future The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend